XML 66 R36.htm IDEA: XBRL DOCUMENT v3.7.0.1
Share-Based Payments (Tables)
 3 Months Ended
Mar. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-based compensation expense included in condensed consolidated statements of income
The following table summarizes share-based compensation expense included in our condensed consolidated statements of income:
 
For the Three Months
Ended March 31,
(In millions)
2017
 
2016
Research and development
$
18.7

 
$
21.4

Selling, general and administrative
29.4

 
34.7

Restructuring charges
—

 
(1.8
)
Subtotal
48.1

 
54.3

Capitalized share-based compensation costs
(2.7
)
 
(3.1
)
Share-based compensation expense included in total cost and expenses
45.4

 
51.2

Income tax effect
(12.4
)
 
(15.2
)
Share-based compensation expense included in net income attributable to Biogen Inc.
$
33.0

 
$
36.0
Summary of share-based compensation expense associated with each of our share-based compensating programs
The following table summarizes share-based compensation expense associated with each of our share-based compensation programs:
 
For the Three Months
Ended March 31,
(In millions)
2017
 
2016
Market stock units
$
9.6

 
$
13.4

Time-vested restricted stock units
26.9

 
30.1

Cash settled performance units
3.5

 
0.2

Performance units
4.5

 
6.9

Employee stock purchase plan
3.6

 
3.7

Subtotal
48.1

 
54.3

Capitalized share-based compensation costs
(2.7
)
 
(3.1
)
Share-based compensation expense included in total cost and expenses
$
45.4

 
$
51.2